Therefore, we investigated the role of mRNA expression quantities of ERCC1, BRCA1, RRM1 and RRM2 in response to chemotherapy and clinical outcome of NSCLC patients. This evidence concerns the gene RRM2 and non-small cell lung carcinoma.